GENENTECH, INC for GENENTECH INC
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Homeland Security HOM
Labor HHS Appropriations - S. 3230 and H.R. 3042 Homeland Security Appropriations S.3181 and H.R. 6947
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Food Industry (safety, labeling, etc.) FOO
Monitor food safety and supply chain issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Trade (domestic/foreign) TRD
Monitor issues related to export rules and regulations International patent issues WTO matters and other international trade issues impacting biotech and pharmaceuticals
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Taxation/Internal Revenue Code TAX
Monitor and report on corporate tax issues; Monitoring proposals on U.S. tax treatment of foreign corporations; S. 506, Stop Tax Haven Abuse Act;
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Copyright/Patent/Trademark CPT
Patent Settlement Issues; Intellectual Property and Process Patent Issues; H.R. 1908; S. 515 & HR. 1260 - Patent Reform Act of 2009; Monitor legislation regarding brand name and generic pharmaceutical agreement, patent fees, and post-grant review reforms.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Health Issues HCR
Pandemic Preparedeness: Tamiflu; Advocate on legislative changes in the health care reform bill regarding biosimilars; Monitor changes to outpatient 340B presecription drug discount program, including related provisions included in HR 4213 - American Jobs and Closing Tax Loopholes Act, and ddraft Senate amendments to the legislation; Labor, Health and Human Services Appropriations bill; H.R. 1548 - Pathway for Biosimilars Act; Health care and biotechnology legislation, including H.R. 3490; Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010", including comparative effectiveness provisions; S. 726/H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act; H.R. 1548 - Pathway for Biosimilars Act; Physician payment disclosure including S. 301; Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for Americans Act; H.R. 3590; Patient Protection and Affordable Care Act H.R. 4872, the Reconciliation Act of 2010; Follow on biologics includuing H.R. 154, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life Savings Medicines Act; H.R. 3962, Affordable health care for America Act; Comparative effectiveness legislation including S. 1213; Patient-Centered Outcomes Research Act of 2009; H.R. 3200, America's Health Future Act; H.R. 1548 - Pathway for Dissimilar Act; Legislative changes in the heatlh care reform bill regarding dissimilars; S. 1679 Affordeable Health Choice Act; S.1796, America's Health future Act of 2009; Pharmacuetical import safety legislation. H.R. 1105 Omnibus Appropriations Act of 2010; Supplemental Appropriations Act of 2010, Food Safety Issues concerning clinlical trials; H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 H.R. 3590 Patient Protetion and Affordable Care Act - FTC issue Ryan White CARE Act reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Medicare/Medicaid MMM
Monitor implementation of Medicare pharmaceutical coverage and reimbusement provisions of P.L. 111-148 - Patient protection and Affordable CAre Act and P.L. 111-152 - Health Care and Education Reconciliation Act; Implementation of H.R. 1; Medicare Prescription Drug and Modernization Act of 2003; Medicare and Medicaid Coverage and Reimbursement; issues relating to Prescription Drug User Fee Act, stimulus provisions and economic recovery; Issues related to comparative effectiveness and follow-on biologics; H.R. 3200 and America's health Future Act of 2009; H.R. 4213, the American jobs, Closing Tax Loopholes and Preventing Outsourcing Act of 2010 - eligibility changes for the 340B program, treatment of certain drugs for computation of Average Manufacturer's Price under the Medicaid program; Participatd in discussions with Senate Aging Comm staff on Medicare coverage payment issues related to cancer biotherapeutics;
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Budget/Appropriations BUD
Following issues related to the budget and appropriations process; Issues related to government purchases of pandemic drugs: Tamiflu; Seek Federal appropriations in the FY11 Labor, Health and Human Services and Education bill regarding pandemic influenza;HIV/AIDS programs and HCV screening, care and treatment; Implementation of H.R. 2346, S. 10554; FY09 Supplemental Appropriations related to preparedness for pandemic influenza; FY11 State Foreign Operations appropriations related to USAID and funding for Pandemic Influenza
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.